tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
US Market

Aurinia Pharmaceuticals (AUPH) Income Statement

Compare
2,104 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q3 2025), Aurinia Pharmaceuticals's total revenue was $73.47M, an increase of 8.41% from the same quarter last year. In Q3, Aurinia Pharmaceuticals's net income was $31.55M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 235.13M$ 175.51M$ 134.03M$ 45.60M$ 50.12M
Gross Profit
$ 206.88M$ 161.37M$ 128.37M$ 44.51M$ 50.12M
Operating Expenses
$ 211.57M$ 253.06M$ 239.84M$ 225.25M$ 154.41M
Depreciation and Amortization
$ 19.45M$ 11.65M$ 2.71M$ 2.76M$ 1.37M
EBITDA
$ 31.73M$ -63.05M$ -103.65M$ -177.44M$ -102.92M
Operating Income
$ -4.69M$ -91.69M$ -111.47M$ -180.74M$ -104.29M
Other Income/Expenses
$ 12.13M$ 14.22M$ 5.12M$ 529.00K$ 1.52M
Pretax Income
$ 7.45M$ -77.47M$ -106.35M$ -180.21M$ -102.77M
Net Income
$ 5.75M$ -78.02M$ -108.18M$ -180.97M$ -102.68M
Per Share Metrics
Basic EPS
$ 0.04$ -0.54$ -0.76$ -1.40$ -0.87
Diluted EPS
$ 0.04$ -0.54$ -0.76$ -1.40$ -0.87
Weighted Average Shares Outstanding
143.06M 143.24M 141.91M 129.37M 118.47M
Weighted Average Shares Outstanding (Diluted)
146.19M 143.24M 141.91M 129.37M 118.47M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History